• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

mit

MIT researchers study the best size for nanoparticles to stop internal bleeding

February 17, 2022 By Sean Whooley

MIT Nanoparticles Internal traumatic injury

MIT researchers are examining how different-sized polymer nanoparticles circulate in the body, with a goal of treating traumatic injuries. Researchers are developing injectable nanoparticles that can attract cells to help stop the bleeding at the site of an internal injury until a patient can get to a hospital for treatment. To highlight the mechanism of […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Nanoparticles, Preclinical Trials Tagged With: Massachusetts Institute of Technology, mit

MIT team working on all-in-one diabetes management devices

January 20, 2022 By Sean Whooley

MIT Insulin Dosing device

MIT researchers are touting a platform aimed at helping patients maintain healthy glucose levels by streamlining the diabetes management process. The MIT researchers say it’s hard for people with diabetes to maintain a treatment regimen. Typically at every meal, they need to estimate carbohydrate content, draw blood to measure blood glucose levels, and calculate the […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development Tagged With: Diabetes, mit

Novo Nordisk Foundation, Harvard, MIT launch research center with focus on diabetes

September 15, 2021 By Sean Whooley

Novo Nordisk Foundation Research Center

The Novo Nordisk Foundation, the Broad Institute of MIT and Harvard have launched an initiative to gain insights into disease mechanisms. To accelerate efforts to mine genetic data for insights into mechanisms — and eventually rationally design treatments — the trio of entities launched the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease based […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Research & Development Tagged With: Broad Institute, Harvard University, mit, Novo Nordisk

This coin-sized smart insulin patch could monitor glucose for diabetes management

February 5, 2020 By Danielle Kirsh

diabetes-patch-research

Researchers at three universities have developed a smart insulin-delivery patch that has the potential to also monitor and manage glucose levels in people with diabetes. The adhesive patch was developed by a team of researchers and bioengineers from UCLA, the University of North Carolina School of Medicine and the Massachusetts Institute of Technology. It is […]

Filed Under: Diabetes Tagged With: Massachusetts Institute of Technology, mit, UCLA, University of North Carolina

6 ways hydrogels are enabling medtech innovation

April 21, 2017 By Danielle Kirsh

Hydrogels are water-based biomaterials developed specifically for human use, according to a Biomaterials journal article. They are a water-swollen polymeric material that doesn’t change its distinct 3D structure. They are formed from super-absorbent, chain-like polymers and are not soluble in water. However, their porous surface allows for nutrients and cell waste to pass through. They have shown the […]

Filed Under: Featured, Hydrogels, Implants, Regenerative Medicine, Research & Development Tagged With: biomaterial, hydrogels, medtech, mit, Northwestern University, retinal detachment, robotics, University of Chicago, University of Tokyo

Fibrosis: How to prevent it in medical device implants

March 21, 2017 By Danielle Kirsh

Massachusetts Institute of Technology (MIT) and Boston Children’s Hospital researchers have discovered a way to prevent fibrosis from forming around medical device implants by blocking certain cells. The body’s immune system usually attacks implanted medical devices that are used for drug delivery, sensing or tissue regeneration. Defense cells in the body try to isolate the […]

Filed Under: Featured, Implants, Research & Development Tagged With: Boston Children's Hospital, fibrosis, glucose monitoring, implantable devices, Massachusetts Institute of Technology, medical devices, medtech, mit

New material illuminates when exposed to chemicals on the body

February 28, 2017 By Danielle Kirsh

hydrogelsensorMD

MIT engineers and biologists teamed up and designed a living-cell-injected hydrogel that can illuminate when exposed to certain chemicals. The MIT team made wearable sensors using the hydrogel with living cells that lit up after touching a surface with certain chemicals. The new material has the potential to detect chemicals in the environment and the […]

Filed Under: Hydrogels Tagged With: bacteria, hydrogels, Massachusetts Institute of Technology, mit

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS